Cancer Burden in India: Evaluating the Cost burden of treatment due to TRIPS

Journal Title: National Journal of Research in Community Medicine - Year 2015, Vol 4, Issue 2

Abstract

Objectives: TRIPS (Agreement on Trade-related aspects of Intellectual Property Rights) is said to have an impact on drug pricing, thereby creating hurdles in the world-wide access to essential medicines. The objective of this paper is to estimate the effect of TRIPS on the cost burden of cancer treatment in India. Methods: Information was obtained through a web search on the world-wide best-selling cancer drugs. A cost comparison was done between the brand rates and the estimated discounted Indian government procurement rates. The estimated discounted government procurement rates were calculated using the average price variation (approx. 44%) between branded drugs and generic drugs on the National List of Essential Medicines. The overall percentage cost savings was estimated using the estimated 5-year prevalence of Cancer in India from the WHO GLOBOCAN 2012 Report. Results: In India, the five most common cancers were cancers of the breast (14.3%), cervix uteri (12.1%), lip-oral (7.6%), lung (6.9%) and colorectal (6.3%), breast cancer being on a constant rise over the years. The top best-selling cancer drugs globally in 2013 for the five most commonly occurring cancers are Bevacizumab ($6.75 billion), Trastuzumab ($6.56 billion), and Cetuximab ($1.87 billion). It was found that these drugs are not produced in India, their biosimilar are not available in India, and is not procured by the Indian government. If these drugs are procured by the Indian government then the estimated percentage savings of the people suffering from the most commonly occurring cancers in India is approximately 58%. Conclusion: Evidence does suggest that patenting presents a significant increase in costs of treatment and a tradeoff exits between current and future access of medicines and related aspects of trade and investments and thus there is a need to encourage the applicability of compulsory licensing and tiered pricing strategy

Authors and Affiliations

Ashwini Reddy, Chandrakiran Dubey, Suresh Munuswamy

Keywords

Related Articles

Preference of teaching methods among medical students: Comparative analysis between large group and Small group teaching

Background: The primary goal of medical education technology is to enhance learning and teaching by introducing various effective teaching methods into the medical curriculum. Lectures are an efficient means of transferr...

A PREVALENCE STUDY ON MALNUTRITION AMONG ELDERLY PERSONS OF KANCHEEPURAM DISTRICT IN TAMILNADU

BACKGROUND: Under nutrition is still a major problem and elderly are highly vulnerable and are often neglected. Early diagnosis and timely intervention can arrest malnutrition at its incipient stage, so as to enable heal...

Prevalence of Cardiovascular Risk Factors among Urban Slum Dwellers in Tamilnadu

Objectives: To study the prevalence of risk factors for cardio vascular disease among 30-65 years and to identity moderate and high risk individual for developing Diabetes using Indian Diabetes Risk Score (IDRS). Methods...

Obstacles to contraceptive use among married women of reproductive age group in Adilabad District

Introduction: Population explosion has been India’s major problem and obstacle to the nation’s overall progress. Adoption of family planning method is one of the best solutions to tackle the problem. While real progress...

Study on Knowledge, Attitude and Practices Regarding Voluntary Blood Donation among Medical Students

Introduction: Blood Transfusion Service (BTS) is an essential part of modern health care system without which medical care is impossible. The provision of safe and adequate blood and blood products at national level is t...

Download PDF file
  • EP ID EP215471
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

Ashwini Reddy, Chandrakiran Dubey, Suresh Munuswamy (2015). Cancer Burden in India: Evaluating the Cost burden of treatment due to TRIPS. National Journal of Research in Community Medicine, 4(2), -. https://europub.co.uk/articles/-A-215471